People · Operator
Named in public records as an officer, director or promoter · active 2016–2016 · Pharmaceuticals
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| SiteOne Therapeutics, Inc. | — | Pharmaceuticals | Series A | $16.1M | $460.3M | 2016 |
Rick E. Orr at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside Rick E. Orr on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Joseph Zakrzewski | 1 | 6 |
| Rick Orr | 1 | 5 |
| Lowell E. Sears | 1 | 4 |
| Will Price | 1 | 4 |
| Stan Abel | 1 | 3 |
| Lowell Sears | 1 | 3 |
| Stan E. Abel | 1 | 1 |
| Will E. Price | 1 | 1 |
| Justin DuBois | 1 | 1 |
| George Miljanich | 1 | 1 |
| Joseph E. Zakrzewski | 1 | 1 |
| Justin E. Du Bois | 1 | 1 |
| John E. Mulcahy | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.